Parameters | Measurement at diagnosis | Measurement after HSCT (4 months) | Normal range |
---|---|---|---|
Hemoglobin, g/L | 57 | 110 | 115–150 |
Platlet,×109/L | 5 | 133 | 100–300 |
Leucocytes, ×109/L | 7.5 | 4.5 | 4–9 |
Lymphocytes, ×109/L | 0.67 | 1.8 | 1.1–3.2 |
B cells, % | 2.8 | 7.26 | 5.1–20.3 |
T cells | 95.2 | 86.74 | 53.7–80.9 |
CD3+CD4+, % | 19.9 | 14.8 | 19.57–48.02 |
CD3+CD8+, % | 75.3 | 71.94 | 15.8–37.5 |
CD4+CD25+FOXP3+,% | 0.23 | 0.49 | 1.11–2.9 |
NK cell, % | 2.0 | 6 | 6.7–30.9 |
Total T/NK lymphocyte, % | 8.96 | 16.94 | 17.06–43.35 |
Cytotoxic T/NK Lymphocyte,% | 2.29 | 3.73 | 2.86–18.22 |
Non-Cytotoxic T/NK Lymphocyte,% | 6.68 | 13.21 | 11.15–35.76 |
IGG, mg/dL | 543 | 1160 | 860–1740 |
IGA, mg/dL | 10 | 79 | 100–420 |
IGM, mg/dL | 18 | 123 | 50–280 |
C3, mg/dL | 78 | 124 | 70–140 |
C4, mg/dL | 19 | 36 | 10–40 |
sCd25, pg/ml | 22914 | 5367 | < 6400 |
NK cytotoxicity | 22.96% | 17.44% | ≥ 15.11% |